Investors / United States / Sanderling Ventures
Sanderling Ventures
Venture capital · San Mateo, CA, United States · North America
Sanderling Ventures is an investment firm founded in 1979 that focuses on building new biomedical companies. It combines a specialized investment focus with active management and long-term commitment to its portfolio companies.
Invests inHealthcare & Biotech
In its own wordsbiomedicaltherapeuticsbiologicsvaccinesdrug deliverymedical devices
Your fit with Sanderling Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSanderling Ventures lists 24 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%) and Media & Entertainment (5%). 82% of its companies are based in United States. It invests most often alongside Aisling Capital, Mesa Verde Venture Partners and Pappas Capital.
Counts come from funding rounds that name Sanderling Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Sanderling Ventures' whole history. Rounds on record name 1 company; its own site lists 24. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 62th | 4% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Aisling Capital | 2 |
| Mesa Verde Venture Partners | 2 |
| Pappas Capital | 2 |
| Abingworth | 1 |
| Advent Life Sciences | 1 |
| Asahi Kasei Ventures | 1 |
| Asset Management Company | 1 |
| Atlas Accelerator | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1979%
- No longer answers00%
- Points to another company521%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Media & Entertainment | 5% | 4% |
Co-investor network
who it backs companies with, and who they back togetherCompare Sanderling Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Sanderling Ventures| Date | Company | Stage |
|---|---|---|
| 16 Apr 2025 | Series C+ |
Round details for Sanderling Ventures
Amounts, full round histories and every co-investor in Sanderling Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
24 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Artielle Immunotherapeutics is a venture-backed company developing novel therapies for neuroinflammatory diseases and advanced cancers | Healthcare & Biotech | Portfolio page | ||
| Asteres develops automated pharmacy pickup kiosks and lockers for secure prescription pickup and storage. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| CalciMedica is a biopharmaceutical company developing investigational treatments for pulmonary hypertension and acute pancreatitis | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| Naviscan provides breast cancer imaging solutions | Healthcare & Biotech | Portfolio page | ||
| DalCor Pharmaceuticals is a biopharmaceutical company focused on addressing cardiovascular disease | Healthcare & Biotech | Portfolio page | ||
| Dendreon develops and manufactures cellular therapies, including immunotherapy | Healthcare & Biotech | Portfolio page | ||
| Digirad provides nuclear imaging and diagnostic services | Healthcare & Biotech | Portfolio page | ||
| Dynavax Technologies is a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Glycomine is developing replacement therapies for rare genetic diseases | Healthcare & Biotech | Apr 2025Series C+ | Page + round | |
| The company develops immunotherapies to treat cancer and infectious diseases | Healthcare & Biotech | Portfolio page | ||
| Infraredx develops and provides intravascular imaging solutions for vascular disease treatment | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Metavention develops a treatment for high blood pressure using a minimally invasive procedure called renal denervation | Healthcare & Biotech | Portfolio page | ||
| Pacira develops and commercializes non-opioid therapies for postsurgical, chronic, and musculoskeletal pain | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- sanderling.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 16 Apr 2025
- Companies checked
- 24
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sanderling Ventures' profile as data
Pull Sanderling Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sanderling.com
# also
GET /v1/firms/sanderling.com/portfolio
GET /v1/firms/sanderling.com/coinvestors
GET /v1/firms/sanderling.com/news